These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 17474433)

  • 1. [Chemotherapy of hematological malignancy; principles of treatment].
    Ueda T; Urasaki Y
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():363-8. PubMed ID: 17474433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy and high-dose chemotherapy].
    Yamauchi T; Ueda T
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():369-74. PubMed ID: 17474434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rituximab and hematological malignancy].
    Hatake K; Mishima Y; Terui Y
    Nihon Rinsho; 2004 Jul; 62(7):1321-4. PubMed ID: 15283150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
    Kami M; Hori A; Takaue Y; Mutou Y
    Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Following-up of nosocomial lower respiratory infection in patients with hematological malignancy after chemotherapy].
    Lu Q; Huang LS; Zhang R; Xu GB; Zhao XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Feb; 42(2):123-6. PubMed ID: 18642667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral molecular targeting agents in hematological malignancy].
    Wakabayashi S; Ohashi K
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1214-8. PubMed ID: 20647701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
    el-Sayed MH; Shanab G; Karim AM; el-Tawil A; Black A; Dixon JS
    Pediatr Hematol Oncol; 2004 Mar; 21(2):145-56. PubMed ID: 15160513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.
    Kemp K; Morse R; Wexler S; Cox C; Mallam E; Hows J; Donaldson C
    Ann Hematol; 2010 Jul; 89(7):701-13. PubMed ID: 20119670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Future directions of antibody therapy].
    Oguro M
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():629-36. PubMed ID: 17474471
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies in the treatment of hematologic malignancy.
    Ball ED; Broome HE
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):403-16. PubMed ID: 21112039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
    Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S
    Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective clinical use of cyclophosphamide in hematological malignancies].
    Miyazaki H; Hirano M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1891-5. PubMed ID: 8978792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of toll-like receptor 9 polymorphism in chemotherapy-related invasive mold infections in children with hematological malignancies.
    Lanciotti M; Pigullo S; Lanza T; Dufour C; Caviglia I; Castagnola E
    Pediatr Blood Cancer; 2008 Apr; 50(4):944. PubMed ID: 17894360
    [No Abstract]   [Full Text] [Related]  

  • 14. [New agents for solid tumours].
    Raida M
    Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation system in patients with blood malignancies treated with estrogens in the course of cytostatic therapy].
    Ignashina EV; Vasil'ev SA; Pivnik AV; Shilin DE; Margolin OV; Kozhurin SV
    Ter Arkh; 1998; 70(10):46-8. PubMed ID: 9864804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the role of dose intensity in hematological malignancies.
    Holmberg LA; Stewart FM
    Exp Hematol; 2006 Jul; 34(7):811-25. PubMed ID: 16797408
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigational antibody-drug conjugates for hematological malignancies.
    Polson AG; Ho WY; Ramakrishnan V
    Expert Opin Investig Drugs; 2011 Jan; 20(1):75-85. PubMed ID: 21142808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?
    Mihu CN; Kassis C; Ramos ER; Jiang Y; Hachem RY; Raad II
    Cancer; 2010 Nov; 116(22):5290-6. PubMed ID: 20665889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.